FGF2 and ulcer disease: In vitro studiesconfirmed excellent biocompatibility, with bFGF promoting cell proliferation,migration, and neovascularization, while DXMS provided anti-inflammatoryeffects by reducing TNF-α and IL-6 levels in HOrF and HUVEC.These findings confirmed the excellent biosafety of the MN patchesand their potential to promote cell activity and proliferation, highlightingtheir promising application in oral ulcer treatment.